Dopaminergic abnormalities following traumatic brain injury

Area of Science:

• Neuroscience
• Radiology
• Neurology

Background:

• Traumatic brain injury (TBI) can disrupt striatal dopamine levels, potentially impacting the nigrostriatal system.
• The precise cause of dopamine reduction post-TBI, especially without motor symptoms, remains unclear.
• Understanding these changes is crucial for diagnosing and managing cognitive deficits after TBI.

Purpose of the Study:

• To investigate striatal dopamine transporter (DAT) abnormalities using 123I-Ioflupane SPECT after moderate-severe TBI.
• To correlate DAT levels with nigrostriatal damage and clinical/neuropsychological features.
• To determine the extent and pattern of dopaminergic system involvement in TBI patients without parkinsonism.

Main Methods:

• 123I-Ioflupane SPECT scans to quantify DAT levels in the striatum of 42 TBI patients and 20 controls.
• Advanced MRI techniques to assess nigrostriatal tract integrity and substantia nigra volume.
• Comprehensive clinical, neuropsychological, and diffusion MRI assessments.

Main Results:

• Approximately 20% of TBI patients exhibited reduced striatal DAT binding ratios, predominantly in the caudate nucleus.
• DAT abnormalities correlated with reduced substantia nigra volume and evidence of nigrostriatal tract damage on diffusion MRI.
• No significant association was found between macroscopic striatal lesions or subregion volumes and DAT binding ratios.
• Lower DAT binding in the caudate was linked to impaired processing speed and executive dysfunction.

Conclusions:

• Moderate-severe TBI affects the dopaminergic system in a significant proportion of patients, even without motor parkinsonism.
• Reduced DAT levels, particularly in the caudate, likely reflect axonal injury and midbrain damage within the nigrostriatal tract.
• These findings highlight the subclinical dopaminergic deficits contributing to cognitive impairments after TBI.